Background: Stereotactic body radiotherapy (SBRT) for pulmonary oligometastatic disease
achieves excellent treatment outcomes in terms of local control and toxicity. Patients treated …

Purpose Stereotactic body radiation therapy (SBRT) is increasingly used in the management
of patients with oligometastatic cancers and is under prospective evaluation by the …

Background Data in the literature suggest the existence of oligometastatic disease, a state in
which metastases are limited in number and site. Different kinds of local therapies have …

Aim: Stage IV non-small cell lung cancer (NSCLC) is characterized by poor prognosis.
Palliative chemotherapy and/or best supportive care are considered standard treatment …

Objectives The current literature on stereotactic body radiotherapy (SBRT) for
oligometastatic disease is characterized by small patient cohorts with heterogeneous …

Stereotactic body radiotherapy (SBRT) is now an established therapy in stage I lung cancer
with comparable local control rates to surgical resection. Owing to the conformity of …

Purpose A systematic review of treatment characteristics, outcomes, and treatment-related
toxicities of stereotactic body radiation therapy (SBRT) for pulmonary oligometastases …

Objectives To evaluate the local control (LC) and long term adverse effects in a series of
patients with lung metastases who received 30 Gy in single dose with stereotactic technique …

Background To investigate the effect of stereotactic body radiation therapy (SBRT) on
pulmonary oligometastases and to analyze the clinical factors and dose parameters …

Introduction Hypofractionated stereotactic body radiotherapy (SBRT) is an emerging
noninvasive technique for the treatment of oligometastatic cancer. The use of small numbers …